DL
Highly rated in
22
conditions
Highly rated in
22
conditions
Check Dr. Doris G. Leung's experience treating your condition:
About Dr. Doris G. Leung

Doris Leung is a Neurologist in Baltimore, Maryland. Leung has been practicing medicine for over 17 years and is highly rated in 22 conditions, according to our data. Her top areas of expertise are Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-Girdle Muscular Dystrophy, Myotonic Dystrophy, and Myotonic Dystrophy Type 2. She is licensed to treat patients in Maryland and California. Leung is currently accepting new patients.

Her clinical research consists of co-authoring 23 peer reviewed articles and participating in 6 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Doris G. Leung it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Doris G. Leung accepts the following insurance:

  •  Ambetter
  •  CareFirst

Call to see if your plan is accepted.
Locations
4940 Eastern Ave, Baltimore, MD 21224
Other Locations
Baltimore, MD 21205
Baltimore, MD 21205
Background & Education
Graduate Institution
Duke University School Of Medicine, 2005
Specialties
Neurology
Licenses
Psychiatry & Neurology in CA
Hospital Affiliations
Howard County General Hospital
Kennedy Krieger Institute
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


6 Clinical Trials

Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Subjects With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
View 3 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors